Satellos Bioscience Inc. (000053104)

On this page

Documents
Profile details
Company identification
Reporting issuer details
Formation details
Financial year end
Size and industry classification
Securities
Associated entities
Previous issuers

Profile details

Profile number
000053104
Status
Public
Full legal company name in English
Satellos Bioscience Inc.
Full legal company name in French
Satellos Bioscience Inc.
Effective from date
13 Aug 2021
This company is an Investment Fund Manager
No
This company is an Underwriter
No
Head office address
15 Allstate Parkway, Suite 600, Markham, Ontario, L3R 5B4, Canada
Mailing address
15 Allstate Parkway, Suite 600, Markham, Ontario, L3R 5B4, Canada
Fax number
 

Company identification

Legal Entity Identifier (LEI)
 

Reporting issuer details

Reporting issuer
Yes
Over-The-Counter (OTC) issuer
No
Exchangeable Security or Credit Support issuer
Not applicable
Capital Pool Company (CPC)
No
Eligible for short form prospectus
Yes
Principal jurisdiction
Ontario
Reporting jurisdiction(s)
Alberta, British Columbia, Ontario

Formation details

Date of formation
13 Aug 2021
Manner of formation
Corporation
Jurisdiction where formed
Canada, [Not Provided]
Chief Executive Officer (CEO) - full legal name
GLEESON, Frank
Chief Financial Officer (CFO) - full legal name
WILLIAMS, Liz

Financial year end

Type of financial year end
Fixed year end
Financial year end
December 31

Size and industry classification

NAICS
541710 - Research and development in the physical, engineering and life sciences
Size of issuer (assets)
$25 million to under $100 million

Securities

Listed on an exchange or other market place
Yes
Exchange or market place
Toronto Stock Exchange (TSX) - MSCL
Nasdaq - MSLE
CUSIP
80401L
ISIN
CA80401L3083

Associated entities

Transfer agent or registrar
Computershare Investor Services Inc.
510 Burrard St. 3rd Floor, Vancouver, British Columbia, V6C 3B9, Canada
F: +1 (604) 661-9438
Auditor
PricewaterhouseCoopers LLP / PricewaterhouseCoopers LLP
Address
PwC Tower, 18 York Street, Suite 2500, Toronto, Ontario, M5J 0B2, Canada

Previous issuers

Previous issuer(s)
13260917 Canada Inc. formerly iCo Therapeutics Inc. (000024061)
Unsaved changes will be lost. Are you sure you wish to exit?
Unsaved changes will be lost. Are you sure you want to cancel?
???label.checkSubmitMsg???